Abstract
Purpose
To clarify the clinicopathologic features of patients surviving ≥20 years after resection for hepatocellular carcinoma (HCC).
Methods
Between 1961 and 1987, a total of 396 patients underwent hepatic resection for HCC; 53 (13.4%) patients survived ≥20 years, and 343 (86.6%) patients survived <20 years. A comparative study between the two groups was made.
Results
By March of 2007, 67.6% (36/53) patients are still alive, disease free; 5.7% (3/53) patients died of tumor recurrence or metastasis; 11.3% (6/53) patients died of liver failure; 5.7% (5/53) patients were lost during follow-up. The longest patient survived 43 years and 2 months. Five young patients got married after resection and have had babies. One patient with a tumor measuring 17 × 13 × 9 cm (largest tumor in this series) survived for 37 years after resection, still alive, free of disease. Reresection for recurrence was done in nine patients, mean survival being 26 years and 11 months. Reresection for solitary pulmonary metastasis was carried out in three patients, mean survival being 29 years and 2 months. In comparison with patients surviving <20 years, patients surviving ≥20 years were significantly younger (P = 0.031), had a higher incidence of asymptomatic tumors (56.6 vs. 34.4%, P = 0.002); lower γ-glutamyl transpeptidase level (≤50 U/L, 64.2 vs. 25.9%, P < 0.000), lower proportion of liver cirrhosis (66.0 vs. 83.6%, P = 0.002); higher percentage of small tumors (≤5 cm, 62.3 vs. 29.9%, P < 0.000), single nodule tumors (90.6 vs. 62.9%, P < 0.000), and well-encapsulated tumors (86.8 vs. 43.6%, P < 0.000); lower proportion of tumor emboli in the portal vein (3.8 vs. 22.5%, P = 0.002), better differentiation of tumor cells (Edmondson grade I, 21.6 vs. 9.1%, P = 0.036), and higher curative resection rate (100 vs. 64.1%, P < 0.000).
Conclusions
Early detection and curative resection are the principal factors improving long-term survival. Long-term follow-up after resection of HCC is very important, and should continue for the remainder of the patient’s life. Reresection for recurrence and metastasis is important approach to improve prognosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Center of health statistics information, Ministry of Public health, Peoples Republic of China (1991) Selected edition on health statistics of China (1978–1990). Ministry of Public Health. Bei**g, pp 78–79
Chedid A, Ryan LM, Dayal Y, Wolf BC, Falkson G (1999) Morphology and other prognostic factors of hepatocellular carcinoma. Arch Pathol Lab Med 123:524–528
Chen XP, Zhang BX, Wu ZD, Qin FZ (2002) Hepatectomy for patients with huge primary liver cancer in Hubei Province of China. Hepatobiliary Pancreat Dis Int 1:46–51
Kubo S, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, Yamamoto T, Ikebe T, Wakasa K, Nishiguchi S, Kinoshita H (2000) Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma. Cancer 88:1016–1024
Nagasue N, Yukaya H, Chang YC, Yamanoi A, Kohno H, Hayashi T, Nakamura T (1990) Assessment of pattern and treatment of intrahepatic recurrence after resection of hepatocellular carcinoma. Surg Gynecol Obstet 171:217–222
Nagasue N, Kohno H, Hayashi T, Uchida M, Ono T, Yukaya H, Yamanoi A (1996) Repeat hepatectomy for recurrent hepatocellular carcinoma. Br J Surg 83:127–131
Nakajima Y, Ko S, Kanamura T, Nagao M, Kanchiro H, Hisanaga M, Aomatsu Y, Ikeda N, Nakano H (2001) Repeat liver resection for hepatocellular carcinoma. J Am Coll Surg 192:339–344
Ng IOL, Ng MMT, Lai ECS, Fan ST (1995) Better survival in female patients with hepatocellular carcinoma. Possible causes from a pathologic approach. Cancer 75:18–22
Poon RTP, Ng IQL, Fan ST, Lai ECS, Lo CM, Liu CL, Wong J (2001) Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol 19:3037–3044
Qin LX, Tang ZY (2002) The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol 8:193–199
Sasaki Y, Imaoka S, Masutani S, Obashi I, Ishikawa O, Koyama H, Iwanage T (1992) Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery 112:512–515
Tang ZY, Yu YQ, Zhou XD, Ma ZC, Yang R, Lu JZ, Lin ZY, Yang BH (1989) Surgery of small hepatocellular carcinoma. Analysis of 144 cases. Cancer 64:536–541
Tang ZY, Yu YQ, Zhou XD, Ma ZC, Lu JZ, Lin ZY, Liu KD, Ye SL, Yang BH, Wang HW, Sun HC (1995) Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: evaluation with analysis of 72 patients. World J Surg 17:784–789
Tang ZY, Yu YQ, Zhou XD (1997) Surgical resection of small hepatocellular carcinoma. In: Wanebo HJ (ed) Surgery for gastrointestinal cancer. Lippinott-Raven, Philadelphia, pp 503–512
Tangkijvanich P, Anukulkarnkusol N, Suwangool P, Lertmaharit S, Hanvivatvong O, Kullavanijaya P, Poovorawan Y (2000) Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol 31:302–308
Villa E, Moles A, Ferretti I, Buttafoco P, Grottola A, Del Buono M, De Santis M, Manenti F (2000) Natural history of inoperable hepatocellular carcinoma: estrogen receptors status in the tumor is the strongest prognostic factor for survival. Hepatology 32:233–238
Wu MC, Shen F (2000) Progress in research of liver surgery in China. World J Gastroenterol 6:773–776
Wu CC, Ho WL, Chen JT, Tang JS, Yeh DC, Peng FK (1999) Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma. Br J Surg 86:1391–1396
Yang JM, Kan T, Chen H, Wu MC (2002) Hepatectomy in the treatment of very big primary liver cancer: report of 86 cases. Hepatobiliary Pancreat Dis Int 1:42–45
Zhou XD, Tang ZY, Yu YQ, Ma ZC, Yang BH, Lu JZ, Lin ZY, Wang J (1991) Solitary minute hepatocellular carcinoma. A study in 14 patients. Cancer 67:2855–2858
Zhou XD, Yu YQ, Tang ZY, Yang BH, Lu JZ, Lin ZY, Ma ZC, Xu DB, Zhang BH, Zheng YX (1993) Surgical treatment of recurrent hepatocellular carcinoma. Hepatogastroenterology 40:333–336
Zhou XD, Tang ZY, Yu YQ, Yang BH, Lu JZ, Lin ZY, Ma ZC, Zhang BH (1994) Recurrence after resection of alpha-fetoprotein-positive hepatocellular carcinoma. J Cancer Res Clin Oncol 120:369–373
Zhou XD, Tang ZY, Yang BH, Lu JZ, Lin ZY, Ma ZC, Ye SL, Wu ZQ, Fan J, Qin LX, Zhang BH (2001) Experience of 1,000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 91:1479–1486
Zhou XD, Tang ZY, Ma ZC, Wu ZQ, Fan J, Qin LX, Zhang BH (2003) Surgery for large primary liver cancer more than 10 cm in diameter. J Cancer Res Clin Oncol 129:543–548
Acknowledgments
The authors thank Wei-De Zhang for conducting the statistical analysis, and Wan-**a **ong for preparing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Present in part at the Hong Kong-Shanghai International Liver Congress, 12–15 June 2008, Hong Kong.
Rights and permissions
About this article
Cite this article
Zhou, XD., Tang, ZY., Ma, ZC. et al. Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases. J Cancer Res Clin Oncol 135, 1067–1072 (2009). https://doi.org/10.1007/s00432-009-0546-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-009-0546-z